β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance. [electronic resource]
Producer: 20120215Description: e23429 p. digitalISSN:- 1932-6203
- Animals
- Antineoplastic Agents -- pharmacology
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cells, Cultured
- Cisplatin -- pharmacology
- Dose-Response Relationship, Drug
- Doxycycline -- pharmacology
- Drug Synergism
- HCT116 Cells
- Humans
- Male
- Melanocytes -- cytology
- Melanoma -- genetics
- Melanoma, Experimental -- genetics
- Mice
- Mice, SCID
- Perylene -- analogs & derivatives
- RNA Interference
- Signal Transduction
- TCF Transcription Factors -- antagonists & inhibitors
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
- beta Catenin -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.